A Randomized, Placebo-Controlled, Dose-Escalation Study to Assess the Safety and Effect of Cidofovir in Renal Transplant Recipients with BK Virus Nephropathy (CASG 209)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/23/067/31/10

Funding

  • University of Alabama at Birmingham (Agmt. 1/23/06 // N01-A1-30025)
  • National Institute of Allergy and Infectious Diseases (Agmt. 1/23/06 // N01-A1-30025)